Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ligand Pharmaceuticals (LGND) Current Leases: 2010-2024

Historic Current Leases for Ligand Pharmaceuticals (LGND) over the last 12 years, with Dec 2024 value amounting to $1.3 million.

  • Ligand Pharmaceuticals' Current Leases rose 2.16% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 2.16%. This contributed to the annual value of $1.3 million for FY2024, which is 208.78% up from last year.
  • According to the latest figures from FY2024, Ligand Pharmaceuticals' Current Leases is $1.3 million, which was up 208.78% from $410,000 recorded in FY2023.
  • In the past 5 years, Ligand Pharmaceuticals' Current Leases ranged from a high of $8.5 million in FY2020 and a low of $410,000 during FY2023.
  • Over the past 3 years, Ligand Pharmaceuticals' median Current Leases value was $715,000 (recorded in 2022), while the average stood at $797,000.
  • As far as peak fluctuations go, Ligand Pharmaceuticals' Current Leases skyrocketed by 575.54% in 2020, and later tumbled by 83.33% in 2021.
  • Yearly analysis of 5 years shows Ligand Pharmaceuticals' Current Leases stood at $8.5 million in 2020, then plummeted by 83.33% to $1.4 million in 2021, then tumbled by 49.40% to $715,000 in 2022, then plummeted by 42.66% to $410,000 in 2023, then surged by 208.78% to $1.3 million in 2024.